CECAD Microsite

Overview

Inflammation is a response of the immune system that aims to defend the organism from pathogens and to promote wound healing and tissue regeneration in response to injury and infection. However, excessive or prolonged inflammation causes tissue damage and is involved in the pathogenesis of a plethora of inflammatory diseases. Chronic inflammation is also implicated in cancer development as well as in ageing and ageing-associated pathologies. Therefore, inflammatory responses need to be tightly regulated to ensure effective host defence and injury repair while preventing excessive tissue pathology and disease. This fine balance between the beneficial and potentially detrimental sides of inflammation is critical for the maintenance of tissue homeostasis and organismal health. Our research aims to understand the mechanisms that regulate inflammation and the pathogenesis of inflammation-related diseases, ultimately aspiring to develop better therapeutic approaches. 

Selected publications

Polykratis A, Martens A, Eren RO, Shirasaki Y, Yamagishi M, Yamaguchi Y, Uemura S, Miura M, Holzmann B, Kollias G, Armaka M, van Loo G, Pasparakis M (2019).
A20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domain. Nat. Cell Biol., in press

Lin J, Kumari S, Kim C, Van T-M, Wachsmuth L, Polykratis A & Pasparakis M (2016). RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature, 540: 124-128

Vlantis K, Wullaert A, Polykratis A, Kondylis V, Dannappel M, Schwarzer R, Welz P, Corona T, Walczak H, Weih F, Klein U, Kelliher M & Pasparakis M (2016) NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions. Immunity 44: 553–567

Kondylis V, Polykratis A, Ehlken H, Ochoa-Callejero L, Straub BK, Krishna-Subramanian S, Van T-M, Curth H-M, Heise N, Weih F, Klein U, Schirmacher P, Kelliher M & Pasparakis M (2015) NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis. Cancer Cell 28: 582–598

Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, Eftychi C, Lin J, Corona T, Hermance N, Zelic M, Kirsch P, Basic M, Bleich A, Kelliher M & Pasparakis M (2014) RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513: 90–94

Welz PS, Wullaert A, Vlantis K, Kondylis V, Fernandez-Majada V, Ermolaeva M, Kirsch P, Sterner-Kock A, van Loo G, Pasparakis M (2011) FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477: 330-334

Bonnet MC, Preukschat D, Welz PS, van Loo G, Ermolaeva MA, Bloch W, Haase I, Pasparakis M (2011) The Adaptor Protein FADD Protects Epidermal Keratinocytes from Necroptosis In Vivo and Prevents Skin Inflammation. Immunity 35: 572-582

Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, Huth M, Nikolaev A, Neufert C, Madison B, Gumucio D, Neurath MF, Pasparakis M (2007) Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446(7135): 557-561

Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R, Roskams T, Trautwein C, Pasparakis M (2007) Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11(2): 119-132

For full list of publications click here:

"A20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domain"

Congratulations to Apostolos and Onur!  

SharedIt link: : https://rdcu.be/bBCOk

Núria Sánchez-Coll and Manolis Pasparakis are happy to organize the EMBO Workshop on Cell death in immunity and inflammation, 06-09 October 2019, Crete, Greece.

For further information and registration, please click click the following link:  http://meetings.embo.org/event/19-cell-death